[1] Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020:GLOBOCANestimates of incidence and mortality worldwide for 36 cancers in 185countries[J].Cancer Journal for Clinicians,2021,35(1):1-41.
[2] Wagle S N,Nogueira L,Devasia P T, et al.Cancer treatmentand survivorship statistics , 2025 .[ J]. CA :a cancer journal forclinicians,2025,75(4):308-340.
[3] 唐耀华, 唐波涌, 唐净.中西医维持治疗晚期癌症临床研究的探讨[J].现代中西医结合杂志,2012,21(21):2381-2383.
[4] 中国癌症基金会,中国抗癌协会肿瘤临床化疗专业委员会,等。中国原发性肺癌诊疗规范(2015 年版)[ C]// 第九届中国肿瘤内科大会论文集,2015:15.
[5] 王学谦,侯炜,郑佳彬,等。中医综合治疗方案维持治疗晚期非小细胞肺癌的多中心队列研究 [J]. 中医杂志,2020,61 (8):690-694.
[6] 刘鹏 .《黄帝内经》通识 [M]. 中华书局:2024:260.
[7] 肖晨曦, 曹文.曹文教授运用 “肺脾肾同治法” 治疗肺癌经验总结[J].广西中医药,2024,47(6):34-37.
[8] 王宁,李萍,张颖。六君子汤对晚期肺癌化疗患者乏力症状及营养状态的影响 [J]. 中国实验方剂学杂志,2020,26(15):86-91.
[9] Zhao Y, Liu X, Chen J, et al. Acupoint application for relievingdyspnea in advanced lung cancer: a randomized controlled trial[J]. JTradit Chin Med, 2021, 41(3):421-427.
[10] 朱丽华,黄弦歌,周蕾,等 . 中医药干预晚期肺癌症状的时效特征研究 [J]. 上海中医药杂志,2023,57(2):34-38.
[11] 陈文怡,王旻,姜丽岩,等 . 培美曲塞联合铂类一线治疗晚期非鳞非小细胞肺癌的临床观察 [J]. 中国癌症杂志,2014,24(8):610-614.
[12] 王娜娜,白羽,刘红,等 . 787 例抗肿瘤药物不良反应特点及预后因素分析 [J]. 肿瘤药学,2019,9(1):143-148.
[13] Zhang Y, Li J, Wang H, et al. Astragalus polysaccharidepromotes proliferation and differentiation of bone marrow hematopoieticstem cells via the Wnt /β-catenin signaling pathway [J]. JEthnopharmacol, 2020, 25(9):112964.
[14] Li M, Zhang L, Liu X, et al. Ferulic acid from Angelica sinensisimproves bone marrow microenvironment in mice with chemotherapy-induced myelosuppression[J]. J Nat Med, 2021, 75(2):389-398.
[15] Huang X, Zhu L, Zhou L, et al. A systematic review and meta-analysis of Chinese herbal medicine for chemotherapy-induced nausea andvomiting in lung cancer[J]. Complement Ther Med, 2022, 64(10):2892.
[16] 管懋莹,周蕾,徐蔚杰,等 . 中医及中西医结合治疗晚期非小细胞肺癌的回顾性队列研究 [J]. 世界中医药,2024,19(17):1462-1468.